Cargando…
Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?
Metabolic disorder is a modifiable risk factor for cardiovascular diseases (CVD), and lifestyle modification is the key to improving metabolic disorder. Diabetes mellitus has been shown to be a risk factor for coronary heart disease (CHD) and ischemic stroke in both Western and Japanese populations....
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405375/ https://www.ncbi.nlm.nih.gov/pubmed/23199129 http://dx.doi.org/10.1007/s13167-011-0074-1 |
_version_ | 1782239123675807744 |
---|---|
author | Kokubo, Yoshihiro |
author_facet | Kokubo, Yoshihiro |
author_sort | Kokubo, Yoshihiro |
collection | PubMed |
description | Metabolic disorder is a modifiable risk factor for cardiovascular diseases (CVD), and lifestyle modification is the key to improving metabolic disorder. Diabetes mellitus has been shown to be a risk factor for coronary heart disease (CHD) and ischemic stroke in both Western and Japanese populations. An association between impaired fasting glucose and pre-hypertension found in an urban Japanese population emphasized the combined risk of CVD. Mean total cholesterol levels in Japan have been increasing in the last three decades. The Japanese evidence for the positive association of total cholesterol with CHD is similar to that in the West. Higher low-density lipoprotein cholesterol (LDL-C) levels pose an increased risk of CHD and atherothrombotic infarction, whereas lower LDL-C levels may pose an increased risk of intracerebral hemorrhage in Japan. Overall, the studies reviewed here show that impaired glucose metabolism and dyslipidemia are emerging risk factors for CVD in the Japanese population. |
format | Online Article Text |
id | pubmed-3405375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-34053752012-07-27 Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? Kokubo, Yoshihiro EPMA J Review Article Metabolic disorder is a modifiable risk factor for cardiovascular diseases (CVD), and lifestyle modification is the key to improving metabolic disorder. Diabetes mellitus has been shown to be a risk factor for coronary heart disease (CHD) and ischemic stroke in both Western and Japanese populations. An association between impaired fasting glucose and pre-hypertension found in an urban Japanese population emphasized the combined risk of CVD. Mean total cholesterol levels in Japan have been increasing in the last three decades. The Japanese evidence for the positive association of total cholesterol with CHD is similar to that in the West. Higher low-density lipoprotein cholesterol (LDL-C) levels pose an increased risk of CHD and atherothrombotic infarction, whereas lower LDL-C levels may pose an increased risk of intracerebral hemorrhage in Japan. Overall, the studies reviewed here show that impaired glucose metabolism and dyslipidemia are emerging risk factors for CVD in the Japanese population. Springer Netherlands 2011-04-02 2011-03 /pmc/articles/PMC3405375/ /pubmed/23199129 http://dx.doi.org/10.1007/s13167-011-0074-1 Text en © European Association for Predictive, Preventive and Personalised Medicine 2011 |
spellingShingle | Review Article Kokubo, Yoshihiro Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? |
title | Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? |
title_full | Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? |
title_fullStr | Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? |
title_full_unstemmed | Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? |
title_short | Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment? |
title_sort | associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from japanese cohort studies for individualized prevention and treatment? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405375/ https://www.ncbi.nlm.nih.gov/pubmed/23199129 http://dx.doi.org/10.1007/s13167-011-0074-1 |
work_keys_str_mv | AT kokuboyoshihiro associationsofimpairedglucosemetabolismanddyslipidemiawithcardiovasculardiseaseswhathavewelearnedfromjapanesecohortstudiesforindividualizedpreventionandtreatment |